Nephrocare Health Services Limited Share Price & Analysis
₹697.05−1.37%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹697.05−1.37%Open
₹708.30High
₹720.00Low
₹692.00Close
₹697.0552W High
₹770.0052W Low
₹445.00Volume
198KLot Size
1Sector
HealthcareMarket Cap
₹7K CrFace Value
₹2Mid Cap
Price Chart
Candle
Range
Fundamentals
P/E
82.40Sector P/E
54.70P/B
1.69EPS
₹8.08ROE
8.83%ROCE
15.30%D/E Ratio
0.07Div Yield
0.00%Book Value
₹111.00Strengths
- Efficient capital deployment (ROCE 15.3%)
- Virtually debt-free
Concerns
- Premium to sector peers (P/E 82.4x vs industry 54.7x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Corporate Events
To consider and approve the financial results for the period ended Jun 30, 2026
Results10 Aug 2026
Latest News
All newsFinancials
Quarterly Results
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹282 Cr 6.0% | ₹266 Cr 2.3% | ₹260 Cr 5.7% | ₹246 Cr 7.9% | ₹228 Cr 4.1% | ₹219 Cr 11.2% | ₹197 Cr |
| Op. Profit | ₹60 Cr 17.6% | ₹51 Cr 16.4% | ₹61 Cr 4.7% | ₹64 Cr 33.3% | ₹48 Cr 5.9% | ₹51 Cr 15.9% | ₹44 Cr |
| OPM | 21.0% 10.5% | 19.0% 17.4% | 23.0% 11.5% | 26.0% 23.8% | 21.0% 8.7% | 23.0% 4.5% | 22.0% |
| Net Profit | ₹32 Cr 6.7% | ₹30 Cr 6.3% | ₹32 Cr 455.6% | ₹-9 Cr 137.5% | ₹24 Cr 4.0% | ₹25 Cr 25.0% | ₹20 Cr |
| EPS (₹) | 3.19 5.3% | 3.03 5.6% | 3.21 161.3% | -5.24 140.0% | 13.1 89.0% | 119.3 23.6% | 96.5 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Revenue | ₹999 Cr 32.1% | ₹756 Cr 33.6% | ₹566 Cr 29.5% | ₹437 Cr 37.4% | ₹318 Cr 11.2% | ₹286 Cr |
| Expenses | ₹774 Cr 31.4% | ₹589 Cr 26.7% | ₹465 Cr 19.5% | ₹389 Cr 28.8% | ₹302 Cr 21.8% | ₹248 Cr |
| Op. Profit | ₹225 Cr 34.7% | ₹167 Cr 65.3% | ₹101 Cr 106.1% | ₹49 Cr 206.3% | ₹16 Cr 56.8% | ₹37 Cr |
| OPM | 23.0% 4.5% | 22.0% 22.2% | 18.0% 63.6% | 11.0% 120.0% | 5.0% 61.5% | 13.0% |
| Other Income | ₹23 Cr 64.3% | ₹14 Cr 75.0% | ₹8 Cr 33.3% | ₹6 Cr 40.0% | ₹10 Cr 100.0% | ₹5 Cr |
| Interest | ₹60 Cr 185.7% | ₹21 Cr 5.0% | ₹20 Cr 25.0% | ₹16 Cr 60.0% | ₹10 Cr 42.9% | ₹7 Cr |
| Depreciation | ₹91 Cr 26.4% | ₹72 Cr 28.6% | ₹56 Cr 19.1% | ₹47 Cr 11.9% | ₹42 Cr 23.5% | ₹34 Cr |
| PBT | ₹97 Cr 11.5% | ₹87 Cr 163.6% | ₹33 Cr 466.7% | ₹-9 Cr 66.7% | ₹-27 Cr 2800.0% | ₹1 Cr |
| Tax % | 21.0% 8.7% | 23.0% 483.3% | -6.0% 116.2% | 37.0% 276.2% | -21.0% 167.7% | 31.0% |
| Net Profit | ₹77 Cr 14.9% | ₹67 Cr 91.4% | ₹35 Cr 391.7% | ₹-12 Cr 42.9% | ₹-21 Cr 2200.0% | ₹1 Cr |
| EPS (₹) | 7.66 97.6% | 321.87 89.5% | 169.82 389.4% | -58.69 45.1% | -106.93 3245.0% | 3.4 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Liabilities | ||||||
| Equity Capital | ₹20 Cr 900.0% | ₹2 Cr 0.0% | ₹2 Cr 0.0% | ₹2 Cr 0.0% | ₹2 Cr 0.0% | ₹2 Cr |
| Reserves | ₹1.1K Cr 89.3% | ₹579 Cr 41.6% | ₹409 Cr 6.5% | ₹384 Cr 1.8% | ₹391 Cr 59.6% | ₹245 Cr |
| Borrowings | ₹80 Cr 69.3% | ₹261 Cr 3.7% | ₹271 Cr 35.5% | ₹200 Cr 68.1% | ₹119 Cr 15.0% | ₹140 Cr |
| Other Liabilities | ₹271 Cr 77.1% | ₹153 Cr 23.4% | ₹124 Cr 53.1% | ₹81 Cr 37.3% | ₹59 Cr 40.5% | ₹42 Cr |
| Total Liabilities | ₹1.5K Cr 47.6% | ₹994 Cr 23.3% | ₹806 Cr 21.0% | ₹666 Cr 16.6% | ₹571 Cr 33.4% | ₹428 Cr |
Assets | ||||||
| Fixed Assets | ₹517 Cr 30.6% | ₹396 Cr 11.2% | ₹356 Cr 49.0% | ₹239 Cr 16.6% | ₹205 Cr 6.8% | ₹192 Cr |
| CWIP | ₹6 Cr 0.0% | ₹6 Cr 500.0% | ₹1 Cr 97.1% | ₹34 Cr 20.9% | ₹43 Cr 2050.0% | ₹2 Cr |
| Investments | ₹178 Cr 249.0% | ₹51 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹767 Cr 41.5% | ₹542 Cr 20.7% | ₹449 Cr 14.2% | ₹393 Cr 22.0% | ₹322 Cr 37.6% | ₹234 Cr |
| Total Assets | ₹1.5K Cr 47.6% | ₹994 Cr 23.3% | ₹806 Cr 21.0% | ₹666 Cr 16.6% | ₹571 Cr 33.4% | ₹428 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Operating CF | ₹233 Cr 72.6% | ₹135 Cr 87.5% | ₹72 Cr 554.5% | ₹11 Cr 21.4% | ₹14 Cr 56.3% | ₹32 Cr |
| Investing CF | ₹-392 Cr 213.6% | ₹-125 Cr 140.4% | ₹-52 Cr 31.6% | ₹-76 Cr 41.5% | ₹-130 Cr 109.7% | ₹-62 Cr |
| Financing CF | ₹157 Cr 190.7% | ₹54 Cr 100.0% | ₹27 Cr 55.0% | ₹60 Cr 50.4% | ₹121 Cr 236.1% | ₹36 Cr |
| Net Cash Flow | ₹-2 Cr 103.1% | ₹65 Cr 38.3% | ₹47 Cr 1275.0% | ₹-4 Cr 166.7% | ₹6 Cr 20.0% | ₹5 Cr |
| Free Cash Flow | ₹113 Cr 222.9% | ₹35 Cr 537.5% | ₹-8 Cr 87.1% | ₹-62 Cr 3.1% | ₹-64 Cr 120.7% | ₹-29 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Debtor Days | 116d 10.1% | 129d 1.5% | 131d 0.8% | 132d 7.3% | 123d 21.8% | 101d |
| Inventory Days | — | — | — | 67d 34.0% | 50d 23.1% | 65d |
| Days Payable | — | — | — | 63d 10.0% | 70d 25.0% | 56d |
| Cash Conv. Cycle | 116d 10.1% | 129d 1.5% | 131d 4.4% | 137d 33.0% | 103d 6.4% | 110d |
| Working Capital Days | 42d 55.6% | 27d 51.8% | 56d 194.7% | 19d 65.5% | 55d 111.5% | 26d |
| ROCE | 15.0% 7.1% | 14.0% 75.0% | 8.0% 700.0% | 1.0% 125.0% | -4.0% | — |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Nephrocare Health Services Limited share price today?
Nephrocare Health Services Limited (NEPHROPLUS) is currently trading at ₹697.05 on NSE, down 1.37% as of the last market session. Prices update daily after market close on MarketNetra.
Is Nephrocare Health Services Limited available in F&O (Futures & Options)?
Yes, Nephrocare Health Services Limited (NEPHROPLUS) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Nephrocare Health Services Limited 52-week high and low?
Nephrocare Health Services Limited's 52-week high is ₹770 and the 52-week low is ₹445. The current price of ₹697.05 is 9.5% below the 52W high.
What is Nephrocare Health Services Limited P/E ratio?
Nephrocare Health Services Limited's current P/E ratio is 82.4. This indicates the market is paying ₹82.4 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Nephrocare Health Services Limited options?
Nephrocare Health Services Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade NEPHROPLUS options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.